SLRN (ACELYRIN) Rega marang bathi mangsa ngarep
Acelyrin, Inc. (SLRN) is developing advanced treatments for severe inflammation, laying the foundation for high cash flow. A chart is available in the GURU.Markets system where the company's forward P/E ratio demonstrates a period of consolidation, and 0.00 shows the current value of the metric. The firm's environmental policy minimizes its carbon footprint and optimizes water consumption. Pricing power will emerge following the confirmation of the new drug's efficacy.
Ringkesan rincian data analitis ACELYRIN Inc. (SLRN)
- rega saiki lan proyeksi nilai saham:
- indikator valuasi pasar bisnis:
- data ekuitas miturut neraca:
- data tingkat utang lan likuiditas finansial:
Total Utang marang Modal Acelyrin, Inc.|SLRN - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas Acelyrin, Inc.|SLRN - Kewajiban utang agregat|Utang-utang marang kapitalisasi buku Acelyrin Inc.|SLRN - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan ACELYRIN|Rasio cepet acelyrin.com
- rincian asil keuangan lan kelipatan valuasi:
SLRN - Penghasilan resik perusahaan|Bathi sing dikarepake Acelyrin, Inc.|SLRN - Rasio rega marang bathi|Prakiraan rega marang bathi ACELYRIN, Inc.|SLRN - Rega marang bathi kanthi panyesuaian wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Acelyrin Inc.|SLRN - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) ACELYRIN|SLRN - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan acelyrin.com|SLRN - Wutah bathi saben saham ing taun iki|Prakiraan wutah bathi saben saham kanggo taun ngarep Acelyrin, Inc.
Pambiji fundamental:ACELYRIN
The forward P/E of Acelyrin, Inc. (SLRN) compares the current market value of shares with projected earnings, allowing for a business valuation amid inflationary pressures. By analyzing the company's forward P/E chart, an investor can see how expected revenues offset high R&D costs and clinical trial risks, which helps determine a fair entry point without overpaying for uncertainty.
Analisis perusahaan pesaing
Prakiraan rega marang bathi HLN (Haleon)|KVUE (Kenvue Inc) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Verona Pharma Corp VRNA|Jyong Bio (MENS) - Rasio prakiraan rega marang bathi|LGND: Prakiraan rega marang bathi|amneal.com - Rasio kapitalisasi marang bathi mangsa ngarep|PRGO: Pangali Forward P/E|Alvotech S.A. - Pangali mangsa ngarep rega marang bathi|LQDA (Liquidia Technologies) - Pangali Forward P/E|Rasio prakiraan rega marang bathi Galapagos Corp GLPG|Rega marang bathi mangsa ngarep ANI Pharmaceuticals (ANIP)|MNKD (mannkindcorp.com) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E AMPH (Amphastar Pharmaceuticals, Inc.)|Pangali Forward P/E Pacira Pharmaceuticals PCRX|ARS Pharma - Pangali Forward P/E|Theravance Corp (TBPH) - Prakiraan rega marang bathi|AQST: Pangali Forward P/E|Rasio prakiraan rega marang bathi scPharmaceuticals (SCPH)|Rega marang bathi mangsa ngarep Tectonic Therapeutic Inc.|Rega marang bathi mangsa ngarep TNXP|Prakiraan rega marang bathi SXTC (China SXT Pharmaceuticals)|EPRX - Rasio prakiraan rega marang bathi|Rega marang bathi mangsa ngarep BioHarvest Sciences BHST|Pangali mangsa ngarep rega marang bathi EXOZ|Oramed Pharma - Pangali Forward P/E|Kapitalisasi marang proyeksi bathi Entera Bio Ltd. ENTX|MindWalk (HYFT) - Rega marang bathi mangsa ngarep|Rasio rega marang bathi mangsa ngarep ABVC|Prakiraan rega marang bathi CPIX|QNTM: Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E FGEN|Kapitalisasi marang proyeksi bathi Telomir Pharmaceuticals Inc|Rega marang bathi mangsa ngarep Rani Therapeutics Holdings, Inc. RANI|SNYR: Rasio rega marang bathi mangsa ngarep|Rallybio Corp. - Pangali Forward P/E|Lexaria Bioscience (LEXX) - Prakiraan rega marang bathi|PULM (Pulmatrix) - Prakiraan rega marang bathi|PTHL - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep Aptorum Group Ltd|Lyra Therapeutics Inc (LYRA) - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep Impact BioMedical Inc (IBO)|Rega marang bathi mangsa ngarep TNFA (tnfpharma.com)|Rega marang bathi mangsa ngarep cbdMD YCBD|Pangali mangsa ngarep rega marang bathi PRFX|CYTO - Rega marang bathi mangsa ngarep|LIPO (Lipella Pharma) - Rasio rega marang bathi mangsa ngarep|OptiNose, Inc. (OPTN) - Rega marang bathi mangsa ngarep|Rasio rega marang bathi sing dikarepake PIRS (pieris.com)|PROC (Procaps) - Pangali Forward P/E|PTPI: Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E QLI|Pangali Forward P/E TFF Pharmaceuticals, Inc (TFFP)
